Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
On monitoring, CGM is described as critical during GLP-1 initiation, with adjustments based on CGM data helping to identify how individual glucose patterns are changing, and starting HbA1c influencing how aggressively monitoring is needed early on
Liraglutide, marketed as Victoza for diabetes and Saxenda for weight management, was one of the first successful GLP-1 drugs

Key Research Areas BPC-157 5mg VEGFR2/ERK1/2 receptor activation and downstream angiogenesis signalling Akt-eNOS nitric oxide pathway and vascular tube formation assays FAK-paxillin pathway fibroblast spreading, migration, and adhesion studies Tendon, ligament, muscle, bone, and skin tissue healing models Anti-inflammatory cytokine modulation TNF-, IL-6 pathway research Gastrointestinal mucosal protection and barrier integrity studies Dose-response research across the full 5mg vial concentration range Key Research Areas TB-500 5mg G-actin sequestration and cytoskeletal reorganisation studies Keratinocyte, endothelial, and stem/progenitor cell migration assays VEGF and actin-binding protein upregulation and angiogenesis initiation Stem and progenitor cell mobilisation and tissue-site differentiation studies Anti-apoptotic signalling and inflammatory cytokine suppression research Cardiac and CNS tissue regeneration pathway studies in pre-clinical models Scar tissue reduction and myofibroblast count modulation research What Do Studies Say About BPC-157 and TB-500

For more information: Tyler Baba, Investor Relations, Manager, WELL Health Technologies, [email protected], 604-628-7266
Plus, Scott revisits his early support for military action in Iran and reflects on how his thinking has changed as the war enters its fourth month